Andreas Bergthaler

Professor Andreas Bergthaler leads the Bergthaler Lab at the Medical University of Vienna and serves as an Adjunct Principal Investigator at CeMM (Research Center for Molecular Medicine of the Austrian Academy of Sciences). His research bridges immunology, virology, and metabolism, focusing on systemic immunometabolism, pathogen surveillance, and transmissible cancers.

• Doctorate in Veterinary Medicine, University of Veterinary Medicine Vienna
• PhD, ETH Zurich & University of Zurich
• Postdoc, University of Geneva & Institute for Systems Biology

His work explores:

• Multi-organ crosstalk in cachexia during chronic infections
• Pathogen surveillance in wastewater and air filters
• Immune evasion in transmissible cancers
• Viral persistence and CD8+ T cell dysfunction

Recent publications highlight advances in:

• 2025: Gut - Metabolic targeting of intestinal inflammation
• 2025: EMBO Mol Med - EGFR signaling in colorectal cancer
• 2024: Nat Metab - Single-cell immunometabolism tools

Recognized with:

• ERC Starting Grant
• Loffler-Frosch Prize (Society of Virology)

He co-founded Hookipa Pharma, developing immunotherapies for infections and cancers, and collaborates across epidemiology, neurobiology, and public health.